Biomarker-based phase II trial of savolitinib in patients with advanced papillary renal cell cancer
- Toni K. Choueiri
- , Elizabeth Plimack
- , Hendrik Tobias Arkenau
- , Eric Jonasch
- , Daniel Y.C. Heng
- , Thomas Powles
- , Melanie M. Frigault
- , Edwin A. Clark
- , Amir A. Handzel
- , Humphrey Gardner
- , Shethah Morgan
- , Laurence Albiges
- , Sumanta Kumar Pal
- Dana-Farber Cancer Institute
- University College London
- University of Texas MD Anderson Cancer Center
- Tom Baker Cancer Centre
- Queen Mary University of London
- AstraZeneca
- Université Paris-Sud
- City of Hope National Medical Center
Research output: Contribution to journal › Article › peer-review
170
Scopus
citations